The Renin Angiotensin System and the Metabolic Syndrome

Overview

Journal Physiol Behav

Specialties Physiology
Psychiatry
Psychology
Social Sciences

Date 2010 Apr 13

PMID 20381510

Citations 83

Authors

Annette D de Kloet

Eric G Krause

Stephen C Woods

Affiliations

Soon will be listed here.

Abstract

The renin angiotensin system (RAS; most well-known for its critical roles in the regulation of cardiovascular function and hydromineral balance) has regained the spotlight for its potential roles in various aspects of the metabolic syndrome. It may serve as a causal link among obesity and several co-morbidities. Drugs that reduce the synthesis or action of angiotensin-II (A-II; the primary effector peptide of the RAS) have been used to treat hypertension for decades and, more recently, clinical trials have determined the utility of these pharmacological agents to prevent insulin resistance. Moreover, there is evidence that the RAS contributes to body weight regulation by acting in various tissues. This review summarizes what is known of the actions of the RAS in the brain and throughout the body to influence various metabolic disorders. Special emphasis is given to the role of the RAS in body weight regulation. The paper represents an invited review by a symposium, award winner or keynote speaker at the Society for the Study of Ingestive Behavior [SSIB] Annual Meeting in Portland, July 2009.

Citing Articles

Anti-inflammatory effect of Angiotensin 1-7 in white adipose tissue.

Nishida N, Sugimoto S, Miyagaki S, Cho C, Konishi M, Goda T Adipocyte. 2025; 14(1):2449027.

PMID: 39803918 PMC: 11730366. DOI: 10.1080/21623945.2024.2449027.

Angiotensin II Alters Mitochondrial Membrane Potential and Lipid Metabolism in Rat Colonic Epithelial Cells.

Toth D, Souder 2nd C, Patuel S, English C, Konig I, Ivantsova E Biomolecules. 2024; 14(8).

PMID: 39199363 PMC: 11353208. DOI: 10.3390/biom14080974.

The effects of ecdysterone and enalapril on nitric oxide synthesis and the markers of oxidative stress in streptozotocin-induced diabetes in rats: a comparative study.

Akopova O, Korkach Y, Sagach V Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):8089-8099.

PMID: 38789633 DOI: 10.1007/s00210-024-03154-z.

Evaluation of prescription medication changes following sleeve gastrectomy surgery.

Arena G, Kitsos A, Hamdorf J, DArcy-Evans M, Kilpatrick M, Venn A Obes Sci Pract. 2024; 10(1):e742.

PMID: 38352066 PMC: 10863745. DOI: 10.1002/osp4.742.

(Pro)renin receptor signaling in hypothalamic tyrosine hydroxylase neurons is required for obesity-associated glucose metabolic impairment.

Pan S, A C Souza L, Worker C, Reyes Mendez M, Gayban A, Cooper S JCI Insight. 2024; 9(6).

PMID: 38349753 PMC: 11063935. DOI: 10.1172/jci.insight.174294.

References

Rowland N, FREGLY M . Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats. Behav Neurosci. 1988; 102(6):953-60. DOI: 10.1037//0735-7044.102.6.953. View

Saavedra J, Chevillard C . Angiotensin-converting enzyme is present in the subfornical organ and other circumventricular organs of the rat. Neurosci Lett. 1982; 29(2):123-7. DOI: 10.1016/0304-3940(82)90340-8. View

James W . The epidemiology of obesity: the size of the problem. J Intern Med. 2008; 263(4):336-52. DOI: 10.1111/j.1365-2796.2008.01922.x. View

Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M . Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun. 2002; 294(2):441-7. DOI: 10.1016/S0006-291X(02)00496-5. View

Wong T, Debnam E, Leung P . Involvement of an enterocyte renin-angiotensin system in the local control of SGLT1-dependent glucose uptake across the rat small intestinal brush border membrane. J Physiol. 2007; 584(Pt 2):613-23. PMC: 2277173. DOI: 10.1113/jphysiol.2007.138578. View

Fujimoto Y, Sasaki T, Tsuchida A, Chayama K . Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett. 2001; 495(3):197-200. DOI: 10.1016/s0014-5793(01)02377-8. View

Weisinger R, Stanley T, Begg D, Weisinger H, Spark K, Jois M . Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiol Behav. 2009; 98(1-2):192-7. DOI: 10.1016/j.physbeh.2009.05.009. View

Chu K, Leung P . Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice. Antioxid Redox Signal. 2007; 9(7):869-78. DOI: 10.1089/ars.2007.1590. View

Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer J . Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002; 109(11):1417-27. PMC: 150992. DOI: 10.1172/JCI14276. View

10.

Schiffrin E, Genest J . Mechanism of captopril-induced drinking. Am J Physiol. 1982; 242(1):R136-40. DOI: 10.1152/ajpregu.1982.242.1.R136. View

11.

Cassis L, Laughter A, Fettinger M, Akers S, Speth R, Burke G . Cold exposure regulates the renin-angiotensin system. J Pharmacol Exp Ther. 1998; 286(2):718-26. View

12.

Cooper R, Forrester T, Ogunbiyi O, Muffinda J . Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens. 1998; 16(5):571-5. DOI: 10.1097/00004872-199816050-00003. View

13.

Elased K, Cunha T, Marcondes F, Morris M . Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice. Exp Physiol. 2008; 93(5):665-75. PMC: 7197900. DOI: 10.1113/expphysiol.2007.040311. View

14.

Tahmasebi M, Puddefoot J, Inwang E, Vinson G . The tissue renin-angiotensin system in human pancreas. J Endocrinol. 1999; 161(2):317-22. DOI: 10.1677/joe.0.1610317. View

15.

Li D, Pan H . Angiotensin II attenuates synaptic GABA release and excites paraventricular-rostral ventrolateral medulla output neurons. J Pharmacol Exp Ther. 2005; 313(3):1035-45. DOI: 10.1124/jpet.104.082495. View

16.

Sloniger J, Saengsirisuwan V, Diehl C, Dokken B, Lailerd N, Lemieux A . Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat. Am J Physiol Endocrinol Metab. 2005; 288(6):E1074-81. DOI: 10.1152/ajpendo.00396.2004. View

17.

Tikellis C, Wookey P, Candido R, Andrikopoulos S, Thomas M, Cooper M . Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes. 2004; 53(4):989-97. DOI: 10.2337/diabetes.53.4.989. View

18.

Nabeshima Y, Tazuma S, Kanno K, Hyogo H, Chayama K . Deletion of angiotensin II type I receptor reduces hepatic steatosis. J Hepatol. 2009; 50(6):1226-35. DOI: 10.1016/j.jhep.2009.01.018. View

19.

Iwai M, Chen R, Imura Y, Horiuchi M . TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation. Am J Hypertens. 2007; 20(5):579-86. DOI: 10.1016/j.amjhyper.2006.12.010. View

20.

Saavedra J, Chevillard C . Angiotensin-converting enzyme in discrete areas of the rat forebrain and pituitary gland. Brain Res. 1982; 245(2):317-25. DOI: 10.1016/0006-8993(82)90814-9. View